LegislativeLabs.ai Logo
Legislative Labs
  • See through the fog of Legislation.
    • FAQ

      Help using Legislative Labs
    • Support

      Contact us for assistance.
    • Legal

      Terms & Conditions.
    • Privacy

      What we do with your information.
    • Sign Up

      Join Legislative Labs to unlock live predictions.
    • Analytics

      Intelligence & analytics on previous sessions.
    • Bill History

      Detailed historical bill information.
    • Sponsor Detail

      Detailed sponsor bill performance.
    • About Us

      The reason for Legislative Labs.
    • startupgrind

      Event overview and demo information.
    • BETA

      Session Dashboard

      Live predictions on introduced legislation.
    • BETA

      Bill Drafting

      Predictions on draft legislation.
    • BETA

      Legitron AI

      Legislation made simple with AI.
    • Session Results

      Legislative session analytics.
    • Sign in

ESB 6228 Information

Legal Title AN ACT Relating to removing a tax exemption for the warehousing and reselling of prescription drugs and providing tax relief for critical access pharmacies;
Description Removing a tax exemption for the warehousing and reselling of prescription drugs. (REVISED FOR ENGROSSED: Removing a tax exemption for the warehousing and reselling of prescription drugs and providing tax relief for critical access pharmacies.)

Details

Date Introduced 01/20/2026
Original Chamber Senate
Biennium 2025-26
Total Campaign Dollars Backing Bill $83,701.18

Bill Topics

TAXES - EXCISE

Sponsors

Senator Frame (Primary)
Senator Dhingra
Senator Hasegawa

Committee Hearings

Hearing Senate Ways & Means (Public)
Hearing Senate Ways & Means (Executive)
Hearing House Finance (Public)
Hearing House Finance (Executive)

ESB 6228 Bill Timeline

Go to ESB 6228 at leg.wa.gov
Became Law
04/01/2026
C 265 L 26
Governor signed.
04/01/2026
C 265 L 26
Chapter 265, 2026 Laws.
04/01/2026
C 265 L 26
Effective date 1/1/2027.
03/13/2026
C 265 L 26
Delivered to Governor.
03/12/2026
C 265 L 26
Senate concurred in House amendments.
03/12/2026
C 265 L 26
Passed final passage; yeas, 26; nays, 23; absent, 0; excused, 0.
03/12/2026
C 265 L 26
President signed.
03/12/2026
C 265 L 26
Speaker signed.
03/11/2026
C 265 L 26
Committee amendment(s) adopted as amended.
03/11/2026
C 265 L 26
Third reading, passed; yeas, 52; nays, 42; absent, 0; excused, 4.
03/09/2026
C 265 L 26
Referred to Rules 2 Review.
03/09/2026
C 265 L 26
Rules Committee relieved of further consideration. Placed on second reading.
03/07/2026
C 265 L 26
FIN - Executive action taken by committee.
03/07/2026
C 265 L 26
FIN - Majority; do pass with amendment(s).
03/03/2026
C 265 L 26
First reading, referred to Finance.
02/28/2026
C 265 L 26
Floor amendment(s) adopted.
02/28/2026
C 265 L 26
Rules suspended. Placed on Third Reading.
02/28/2026
C 265 L 26
Third reading, passed; yeas, 25; nays, 23; absent, 0; excused, 1.
02/27/2026
C 265 L 26
Placed on second reading by Rules Committee.
02/23/2026
C 265 L 26
Minority; do not pass.
02/23/2026
C 265 L 26
Minority; without recommendation.
02/23/2026
C 265 L 26
Passed to Rules Committee for second reading.
02/19/2026
C 265 L 26
WM - Majority; do pass.
01/20/2026
C 265 L 26
First reading, referred to Ways & Means.

You have 3 pending action.

Legitron™ is a trademark of Legislative Labs, Inc.

© 2026 - Legislative Labs